Diabetes mellitus secondary to L-asparaginase therapy.
D001215:Asparaginase / Q000008:administration & dosage / Q000009:adverse effects*; D003920:Diabetes Mellitus / Q000139:chemically induced* / Q000188:drug therapy; D006801:Humans; D007328:Insulin / Q000627:therapeutic use; D007938:Leukemia / Q000188:drug therapy
D007328:Insulin; D001215:Asparaginase